Coca-Cola will not run an ad during the Super Bowl this year. Instead the iconic beverage company will show a commercial before the game starts. Ads during the big game on CBS this year will cost up to $5.3 million. Before kickoff, they are reportedly half of that. According to Coca-Cola, its commercial before the Super Bowl will focus on diversity. The ad will feature cartoon characters telling viewers that the drink is “for everyone.”
The Super Bowl Is Too Big For Controversy
Ad Acreage Holdings, a U.S. marijuana company, says CBS rejected its 30-second commercial. George Allen, president of Acreage Holdings, said the ad doesn’t focus on its products but shows how medical marijuana has helped people deal with pain. The company will publish a 60-second version of the ad on its website. Allen said his company was willing to spend up to $5 million on a spot during this year’s big game.
A Prime Example of Amazon Having Fun
You would be hard pressed to find a more successful company than Amazon but that doesn’t mean even they can’t poke fun at some ideas that haven’t worked. The commercial starts out with people discussing the Alexa microwave, which is a real product, before “pitching” ideas that wouldn’t get people excited for voice activated appliances.
For the latest news, videos, and podcasts in the Sports & Entertainment Industry, be sure to subscribe to our industry publication.
Behind the sterile labels of “inpatient” versus “observation” care is a messy reality: clinicians and insurers often enter peer-to-peer reviews without a shared rulebook, turning what should be a clinical dialogue into a box-checking exercise. The speaker’s frustration points to a broader problem in U.S. healthcare utilization management—decisions about coverage can feel pre-decided,…
A physician advisor recently described a case that should unsettle anyone who cares about fair, clinically grounded coverage decisions: a Medicaid patient arrived comatose from an overdose, was emergently intubated, developed aspiration pneumonia, and stayed through three midnights before leaving against medical advice. By any bedside standard, this is acute, unstable care—exactly what…
Insurance denials aren’t new, but they’re hitting a breaking point right now. As prior authorizations surge and patients face longer delays for everything from imaging to specialty drugs, more providers are realizing that the “payer” on the card often isn’t the one truly holding the reins. A growing share of Americans are covered…
More and more hospital environments rely on continuous, high-quality data to support faster clinical decisions, but much of today’s patient monitoring still varies widely by unit, device, and workflow. This episode kicks off a five-part Health and Life Sciences at the Edge series exploring The Future of Patient Monitoring. Intel’s Kaeli Tully, Solutions Engineer…
The college football carousel is spinning faster than ever—accelerated by the transfer portal, NIL, and playoff-or-bust expectations. In this environment, staff turnover isn’t just a headline; it’s a human story affecting assistants and families who don’t have eight-figure buyouts. As discussed in this episode, a widely cited estimate suggests a majority of portal entrants…
Welcome to the second episode in our mini-series on the alternative asset market. Gennaro Leo is a sports executive and the co-founder of Austin Sports Ventures, a firm that partners with venture capital and private equity firms to invest in and operate assets across professional sports leagues, teams, and high-growth technology startups. In this…